Description

Lupisulin M-30 (30/70) Penfil is a medicine that contains Biphasic Isophane Insulin as its active ingredient. Biphasic Isophane Insulin is a mixture of fast-acting and intermediate-acting insulin, designed to regulate blood glucose levels in individuals with diabetes. This medicine is used in the treatment of type 1 and type 2 diabetes, both for adults and children. It assists in controlling blood sugar levels by mimicking the natural insulin produced by the pancreas. Lupisulin M-30 (30/70) Penfil is administered through a pen device, allowing easy self-injection. The composition of 30/70 indicates that it contains 30% of fast-acting insulin and 70% of intermediate-acting insulin, which provides a balanced effect throughout the day. Lupisulin M-30 (30/70) Penfil is an important tool in managing diabetes and improving the quality of life for diabetic patients.

Additional information